Get the Stockscreener App
0.6818
0.34%
0.0023
After Hours:
.70
0.0182
+2.67%
Aethlon Medical Inc Stock (AEMD) Latest News
Head-To-Head Review: NeuroPace (NASDAQ:NPCE) vs. Aethlon Medical (NASDAQ:AEMD) - Defense World
Critical Analysis: Aethlon Medical (NASDAQ:AEMD) and Becton, Dickinson and Company (NYSE:BDX) - Defense World
Stock Of Aethlon Medical Inc (NASDAQ: AEMD) Dropped By -13.43 Percent Over The Past Month, Is There Room For Downside? – Marketing Sentinel - Marketing Sentinel
Aethlon Medical Inc (AEMD) Stock: A Value Analysis - The News Heater
Aethlon Medical Inc (AEMD) Stock: A Year of Market Movement, Down and Up - The InvestChronicle
Aethlon Medical Q3 Earnings Preview: Cancer & Infectious Disease Pipeline Takes Center Stage - StockTitan
Exosome Diagnostics & Therapeutics Market to Grow by USD 1.01 Billion (2025-2029) with Rising Research in Exosome Therapeutics Boosting the Market, Report on How AI is Driving Market TransformationTechnavio - The Malaysian Reserve
Aethlon Medical (AEMD) Projected to Post Earnings on Wednesday - Defense World
Aethlon Medical (NASDAQ:AEMD) Earns Buy Rating from HC Wainwright - Defense World
Aethlon Medical treats first subject with Hemopurifier device in Australia - Medical Device Network
Medical Therapeutic Stock Aethlon Medical, Inc. (NASDAQ: $AEMD) Gains on Cancer Clinical Trial update - Investorideas.com newswire
Breaking Medical Technology News: Aethlon Medical (NASDAQ: AEMD) Treats First Patient in Australian Hemopurifier® Cancer Trial - Investorideas.com newswire
Aethlon announces treatment of first patient with Hemopurifier in Australia - TipRanks
Revolutionary Blood Filter Could Boost Cancer Immunotherapy Success Rates by 60% - StockTitan
Mawson Infrastructure Group Inc. Provides Company Presentation UpdateOn January 27, 2025, Mawson Infrastructure Group Inc. (NASDAQ: MIGI) announced an updated Company Presentation, disclosing information that has been made available to the publ - Defense World
Aethlon Medical, Inc. (NASDAQ:AEMD) Short Interest Up 201.5% in January - Defense World
Aethlon Medical (NASDAQ:AEMD) Now Covered by Analysts at StockNews.com - Defense World
StockNews.com Initiates Coverage on Aethlon Medical (NASDAQ:AEMD) - Defense World
Aethlon Medical, Inc. (NASDAQ:AEMD) Short Interest Up 201.5% in December - Defense World
Biostage (OTCMKTS:BSTG) and Aethlon Medical (NASDAQ:AEMD) Head to Head Review - Defense World
Aethlon Medical (NASDAQ:AEMD) Coverage Initiated at StockNews.com - Defense World
Head-To-Head Survey: Aethlon Medical (NASDAQ:AEMD) & West Pharmaceutical Services (NYSE:WST) - Defense World
Aethlon Medical receives extension to meet Nasdaq listing requirements - Investing.com
Aethlon Medical receives extension to meet Nasdaq listing requirements By Investing.com - Investing.com UK
Pre-market Movers: SANA, SLDB, JSPR, DRIO... - RTTNews
Will Aethlon Medical Inc (NASDAQ: AEMD) Stock Boom Or Bust From Here? - Marketing Sentinel
Co-Diagnostics (NASDAQ:CODX) and Aethlon Medical (NASDAQ:AEMD) Critical Review - Defense World
Aethlon Medical, Inc. (NASDAQ:AEMD) Sees Large Growth in Short Interest - Defense World
Aethlon Medical (NASDAQ:AEMD) Earns Sell Rating from Analysts at StockNews.com - Defense World
Aethlon Medical (NASDAQ:AEMD) Stock Passes Above 200-Day Moving Average – Here’s Why - Defense World
Analyzing SeaStar Medical (NASDAQ:ICU) & Aethlon Medical (NASDAQ:AEMD) - Defense World
Aethlon Medical Provides Update on the Ability of Its Hemopurifier® to Capture H5N1 Bird Flu - PR Newswire
Aethlon Medical's Hemopurifier Shows 99% Bird Flu Virus Removal in Lab Tests Amid U.S. Outbreak - StockTitan
Why Sangamo Therapeutics Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket - Benzinga
Head-To-Head Analysis: AtriCure (NASDAQ:ATRC) and Aethlon Medical (NASDAQ:AEMD) - Defense World
Aethlon Medical, Inc. (NASDAQ:AEMD) Short Interest Down 42.1% in November - Defense World
StockNews.com Begins Coverage on Aethlon Medical (NASDAQ:AEMD) - Defense World
Presenting on the Emerging Growth Conference 77 Day 1 on December 4th Register Now - GlobeNewswire
Aethlon Medical, Inc. (NASDAQ:AEMD) Short Interest Up 22.7% in November - Defense World
Why Tesla Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket - Benzinga
HC Wainwright Reaffirms Buy Rating for Aethlon Medical (NASDAQ:AEMD) - Defense World
Aethlon Medical, Inc. (NASDAQ:AEMD) Q2 2025 Earnings Call Transcript - Insider Monkey
Maxim retains hold on Aethlon Medical shares amid clinical progress By Investing.com - Investing.com UK
Aethlon Medical Advances Cancer Trial, Expands Hemopurifier Study Sites Globally | AEMD Stock News - StockTitan
Aethlon Medical Inc (AEMD) Q2 2025 Earnings Call Highlights: Progress in Oncology Trials and ... - Yahoo Finance
Aethlon Medical Reports Progress in Oncology Trials - TipRanks
Aethlon Medical Advances Oncology Trials and Global Expansion - TipRanks
Aethlon Medical Announces Financial Results for the Fiscal Second Quarter Ended September 30, 2024 and Provides Corporate Update - Kilgore News Herald
Aethlon Medical Launches Groundbreaking Cancer Trial for Hemopurifier Device in Australia | AEMD Stock News - StockTitan
AEMDAETHLON MEDICAL INC Latest Stock News & Market Updates - StockTitan
0.38%
1.34%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):